Jefferies Group LLC Omeros Corp Put Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$3.09 - $7.46 $2.37 Million - $5.73 Million	-767,700 Reduced 77.59%	221,700 $698,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $2.37 Million - $5.73 Million	-767,700 Reduced 77.59%	221,700 $698,000
Q2 2022 Sep 21, 2023	SELL	$1.92 - $6.28 $404,352 - $1.32 Million	-210,600 Reduced 17.55%	989,400 $2.72 Million
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $404,352 - $1.32 Million	-210,600 Reduced 17.55%	989,400 $2.72 Million
Q1 2022 Sep 21, 2023	BUY	$5.07 - $7.2 $4.96 Million - $7.04 Million	978,300 Added 441.27%	1,200,000 $7.21 Million
Q1 2022 May 16, 2022	BUY	$5.07 - $7.2 $6.08 Million - $8.64 Million	1,200,000 New	1,200,000 $7.21 Million
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $1.19 Million - $2.7 Million	-110,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $992,700 - $2.22 Million	110,300 New	110,300 $1.23 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $423M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.